Sp439

PANEL DISCUSSION

Date
May 19, 2024

Presenters

Speaker Image for Marlies Meisel
University of Pittsburgh School of Medicine
Speaker Image for Sahil Khanna
Mayo Clinic
Speaker Image for Michal Handzlik
Speaker Image for Paul Carlson

Tracks

Related Products

Thumbnail for AASLD Basic Science Emerging Topic Conference Day 2 $$$
AASLD Basic Science Emerging Topic Conference Day 2 $$$
SOCIETY: AASLD Please note that this session requires an additional registration fee to attend…
Thumbnail for EXPLORING MICROBIOME WITH MULTIFACETED EXPERTS: LIVER DISEASE, INFECTIOUS DISEASES, METABOLIC DISORDERS AND DIABETES AND CLINICAL TRIALS
Thumbnail for TRANSLATING MICROBIOME DISCOVERIES: PIONEERING CLINICAL TRIALS IN GASTROINTESTINAL HEALTH
Thumbnail for SAFETY OUTCOMES AND CONCOMITANT MEDICATION CHANGES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE BEING TREATED WITH RBX2660 FOR RECURRENT <i>CLOSTRIDIOIDES DIFFICILE</i> INFECTION
SAFETY OUTCOMES AND CONCOMITANT MEDICATION CHANGES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE BEING TREATED WITH RBX2660 FOR RECURRENT <i>CLOSTRIDIOIDES DIFFICILE</i> INFECTION
BACKGROUND: Recurrent _Clostridioides difficile _infection (rCDI) is a debilitating disease associated with significant healthcare burden and low quality of life. The greatest risk factor for rCDI is a history of recurrence, although older age (≥65 years) and comorbidities also increase risk…